Search Results - "Rogers, Jennifer L."

Investigating Health Literacy in Systemic Lupus Erythematosus: a Descriptive Review by Maheswaranathan, Mithu, Cantrell, Sarah, Eudy, Amanda M., Rogers, Jennifer L., Clowse, Megan E. B., Hastings, Susan N., Bailey, Stacy Cooper

“…Purpose of Review Inadequate health literacy is common among American adults, but little is known about the impact of health literacy in rheumatic diseases…”
Get full text

Molecular endotypes of type 1 and type 2 SLE by Robl, Robert, Eudy, Amanda, Bachali, Prathyusha S, Rogers, Jennifer L, Clowse, Megan, Pisetsky, David, Lipsky, Peter

“…ObjectiveTo character the molecular landscape of patients with type 1 and type 2 SLE by analysing gene expression profiles from peripheral blood.MethodsFull…”
Get full text

Interpreting hydroxychloroquine blood levels for medication non-adherence: a pharmacokinetic study by Balevic, Stephen, Sun, Kai, Rogers, Jennifer L, Eudy, Amanda, Sadun, Rebecca Eli, Maheswaranathan, Mithu, Doss, Jayanth, Criscione-Schreiber, Lisa, O'Malley, Tyler, Clowse, Megan, Weiner, Daniel

“…ObjectiveCharacterise the relationship between hydroxychloroquine (HCQ) blood levels and the number of missed doses, accounting for dosage, dose timing and the…”
Get full text

Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms by Eudy, Amanda M, Rogers, Jennifer L, Corneli, Amy, McKenna, Kevin, Maheswaranathan, Mithu, Pisetsky, David S, Criscione-Schreiber, Lisa G, Doss, Jayanth, Sadun, Rebecca E, Sun, Kai, Clowse, Megan E B

“…ObjectiveWe have developed a new conceptual model to characterise the signs and symptoms of SLE: the Type 1 and 2 SLE Model. Within the original model, Type 1…”
Get full text

Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue by Martin, Mona L., Hill, Jennifer N., Rogers, Jennifer L., Chauhan, Deven, Chen, Wen-Hung, Gairy, Kerry

“…Background Lupus nephritis (LN), a severe organ manifestation of systemic lupus erythematosus (SLE), significantly impacts health-related quality of life…”
Get full text

Development and psychometric evaluation of a physician global assessment for type 2 systemic lupus erythematosus symptoms by Clowse, Megan E B, Rogers, Jennifer L, Coles, Theresa, Pisetsky, David S, Criscione-Schreiber, Lisa G, Burshell, Dana, Doss, Jayanth, Sadun, Rebecca E, Sun, Kai, Maheswaranathan, Mithu, Eudy, Amanda M

“…ObjectiveManifestations of SLE can be categorised as type 1 (classic signs and symptoms of SLE) or type 2 (fatigue, widespread pain and brain fog with an…”
Get full text

Using PROMIS-29 to determine symptom burdens in the context of the Type 1 and 2 systemic lupus erythematosus (SLE) model: a cross sectional study by Sun, Kai, Eudy, Amanda M., Harris, Nathaniel, Pisetsky, David S., Criscione-Schreiber, Lisa G., Sadun, Rebecca E., Doss, Jayanth, Clowse, Megan E. B., Rogers, Jennifer L.

“…Objective To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge discrepancies between patient- and physician-perceived SLE activity, we…”
Get full text

Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats by Rogers, Jennifer L, Mitchell, Adam R, Maric, Christine, Sandberg, Kathryn, Myers, Adam, Mulroney, Susan E

“…Although the mechanisms are not understood, evidence suggests that 17beta-estradiol (E2) confers protection from cardiovascular and renal complications in many…”
Get more information

Racial Disparities in Medication Adherence between African American and Caucasian Patients With Systemic Lupus Erythematosus and Their Associated Factors by Sun, Kai, Eudy, Amanda M., Criscione‐Schreiber, Lisa G., Sadun, Rebecca E., Rogers, Jennifer L., Doss, Jayanth, Corneli, Amy L., Bosworth, Hayden B., Clowse, Megan E. B.

“…Objective Medication nonadherence is more common in African Americans compared with Caucasians. We examined the racial adherence gaps among patients with…”
Get full text

Dispositional Feedback: Interpersonally Rich and Creative Approaches by Luke, Melissa, Rogers, Jennifer L.

“…While there is increasing recognition of the need for counselor education programs to identify criteria by which students' professional dispositions and…”
Get full text

A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus by Pisetsky, David S., Clowse, Megan E. B., Criscione‐Schreiber, Lisa G., Rogers, Jennifer L.

Get full text

Using Clinical Characteristics and Patient‐Reported Outcome Measures to Categorize Systemic Lupus Erythematosus Subtypes by Rogers, Jennifer L., Eudy, Amanda M., Pisetsky, David, Criscione-Schreiber, Lisa G., Sun, Kai, Doss, Jayanth, Clowse, Megan E. B.

“…Objective The type 1 and type 2 systemic lupus erythematosus (SLE) categorization system was recently proposed to validate the patients’ perspective of disease…”
Get full text

The Association Between Implicit Racial Bias and Mindfulness in Mental Health Practitioners by Ivers, Nathaniel N., Johnson, David A., Rogers, Jennifer L.

“…The mental health research literature on implicit bias is limited (Boysen, 2009), and little is known about how factors that are associated with self‐perceived…”
Get full text

Nanoparticle-based diagnostic imaging of inflammation in rheumatic disease by Rogers, Jennifer L, Tarrant, Teresa, Kim, Jason S

“…A variety of imaging modalities assists in the diagnosis and assessment of rheumatoid arthritis and of other rheumatic disorders; however, the definitive…”
Get more information

Implementation of a Clinician-led Medication Adherence Intervention Among Patients With Systemic Lupus Erythematosus by Sun, Kai, Molokwu, Nneka J, Hanlen-Rosado, Emily, Corneli, Amy L, Pollak, Kathryn I, Rogers, Jennifer L, Sadun, Rebecca E, Criscione-Schreiber, Lisa G, Doss, Jayanth, Bosworth, Hayden B, Clowse, Megan E B

“…Medication nonadherence in systemic lupus erythematosus (SLE) leads to poor clinical outcomes. We developed a clinician-led adherence intervention that…”
Get full text

Patient and Physician Perspectives of Systemic Lupus Erythematosus Flare: A Qualitative Study by Rogers, Jennifer L, Clowse, Megan E B, McKenna, Kevin, Starling, Summer, Swezey, Teresa, Molokwu, Nneka, Corneli, Amy, Pisetsky, David S, Sun, Kai, Criscione-Schreiber, Lisa G, Sadun, Rebecca E, Maheswaranathan, Mithu, Burshell, Dana, Doss, Jayanth, Eudy, Amanda M

“…Systemic lupus erythematosus (SLE) flares are associated with increased damage and decreased health-related quality of life. We hypothesized that there is…”
Get full text

Barriers to Taking Medications for Systemic Lupus Erythematosus: A Qualitative Study of Racial Minority Patients, Lupus Providers, and Clinic Staff by Sun, Kai, Corneli, Amy L., Dombeck, Carrie, Swezey, Teresa, Rogers, Jennifer L., Criscione‐Schreiber, Lisa G., Sadun, Rebecca E., Eudy, Amanda M., Doss, Jayanth, Bosworth, Hayden B., Clowse, Megan E. B.

“…Objective Underrepresented racial and ethnic minorities are disproportionately affected by systemic lupus erythematosus (SLE). Racial and ethnic minorities…”
Get full text

Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence by Sun, Kai, Coles, Theresa M, Voils, Corrine I, Anderson, D Ryan, Eudy, Amanda M, Sadun, Rebecca E, Rogers, Jennifer L, Criscione-Schreiber, Lisa G, Doss, Jayanth, Maheswaranathan, Mithu, Clowse, Megan E B

“…Medication nonadherence is common in patients with systemic lupus erythematosus (SLE) and negatively affects outcomes. To better recognize and address…”
Get full text

Association of Hurried Communication and Low Patient Self‐Efficacy With Persistent Nonadherence to Lupus Medications by Barr, Ann Cameron, Clowse, Megan, Maheswaranathan, Mithu, Eder, Lena, Eudy, Amanda M., Criscione‐Schreiber, Lisa G., Rogers, Jennifer L., Sadun, Rebecca E., Doss, Jayanth, Sun, Kai

“…Objective Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented…”
Get full text

Development and Initial Validation of a Systemic Lupus Erythematosus-Specific Measure of the Extent of and Reasons for Medication Nonadherence by Sun, Kai, Coles, Theresa M, Voils, Corrine I, Anderson, D Ryan, Eudy, Amanda M, Sadun, Rebecca E, Rogers, Jennifer L, Criscione-Schreiber, Lisa G, Doss, Jayanth, Maheswaranathan, Mithu, Clowse, Megan E B

Get full text